In brief
- A survey of 163 people living in US municipalities with decriminalized psychedelics finds perceived improvements in safety, access to therapy, and well-being.
- 84% report improvements in at least one legal or safety aspect; 5.5% perceive some worsening, and no one reported an increase in legal risk.
- This is a convenience sample, self-reported and without a control group: it does not allow for claims of cause and effect.
A community survey conducted among people who use psychedelics in cities across California, Colorado, and Michigan—where these substances have been locally decriminalized—finds that the majority perceive improvements in safety, access to therapeutic support, and their overall lives since criminal prosecution ceased to be the norm. The study, authored by Daniel J. Kruger, Julie Barron, and Larry Norris in the journal Social Sciences, is among the first to attempt to quantify what happens on the ground when a city council stops prosecuting the possession of mushrooms, ayahuasca, or mescaline.
What was asked and to whom
The team collected 163 valid responses from people who use psychedelic substances and reside in municipalities with some form of local decriminalization, a movement that began in Denver in 2019 and has since spread to dozens of cities and states like Oregon and Colorado. The sample was recruited via convenience, through networks and organizations within the psychedelic community itself, and the authors acknowledge the bias: the profile is predominantly white (78.5%), college-educated, and experienced with frequent use. It is not a snapshot of the general population, but rather of those already involved in the community.
What people living under decriminalization say
84% of respondents noted improvements in at least one of these aspects: legal risk, social acceptance, availability, substance safety, product variety, or quality. Only 5.5% perceived any worsening, and not a single person said that legal risk had increased. Nearly 75% noticed improvements in access to psychedelic-assisted therapy and 72.4% in their general living conditions, compared to 2.5% who perceived a decline. About half reported less stress and anxiety and a greater sense of community; more than a third reported improvements in depressive symptoms and their relationships. A finding of interest to those who follow harm reduction: more than 27% claimed to have stopped or reduced their use of conventional medication, a figure that should be interpreted with caution as it is based on self-reporting rather than medical follow-up. The survey also recorded a shift in how material is obtained, with more home cultivation, more online purchasing, and more physical storefronts—a trade that decriminalization ordinances usually do not authorize and which comes with its own risks: one in five respondents said they had been scammed at least once while purchasing.
What it implies
The researchers themselves highlight the limitations: it is a cross-sectional survey, without a control group, using a small, self-selected sample of people already favorable to these substances. It does not establish a cause-and-effect relationship, only a perception. Barron further explains why they relied on a survey rather than official records: tracking emergency room visits or 911 calls related to psychedelics is nearly impossible because they are not coded as such, but rather fall into a generic drug category. Nevertheless, the pattern aligns with what harm reduction organizations have maintained for years: when the fear of police decreases, people speak more candidly about their use, seek help sooner, and access support with fewer barriers. It is one more data point, not definitive proof, in a country where dozens of different local policies coexist while federal law remains stagnant.
Source
- Gorsline J. Decriminalizing Psychedelics Improves Safety And Wellbeing, Study Concludes. Marijuana Moment, August 27, 2026.
- Kruger DJ, Barron J, Norris L. Perceptions of Psychedelic Decriminalization: Findings from a Community Survey of People Who Use Psychedelics. Social Sciences 15(9):569, August 23, 2026. DOI: 10.3390/socsci15090569.
Educational content written from a harm reduction perspective and with respect for individual freedom. It is not a substitute for advice from a healthcare professional and is not intended to encourage or condemn any drug use.
